Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Resource Type
Article
Authors
Choueiri, T.K. ; Motzer, R.J. ; Rini, B.I. ; Haanen, J. ; Campbell, M.T. ; Venugopal, B. ; Kollmannsberger, C. ; Gravis-Mescam, G. ; Uemura, M. ; Lee, J.L. ; Grimm, M.-O. ; Gurney, H. ; Schmidinger, M. ; Larkin, J. ; Atkins, M.B. ; Pal, S.K. ; Wang, J. ; Mariani, M. ; Krishnaswami, S. ; Cislo, P. ; Chudnovsky, A. ; Fowst, C. ; Huang, B. ; di Pietro, A. ; Albiges, L.
Source
In Annals of Oncology August 2020 31(8):1030-1039
Subject
Urogenital tumors
Language
ISSN
0923-7534